Sign in
4

Changes in Ownership

Teladoc Health, Inc. Filed Acc 0001415889-22-002583

SVP - BUSINESS DEVELOPMENT sold 1,754 shares at $70.24 ($123,199)

  • SVP - BUSINESS DEVELOPMENT acquired 5,785 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise +1,205 8,761 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise +2,050 10,811 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise +515 11,326 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise +1,147 12,473 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise +868 13,341 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-03 Sale −1,754 $70.24 $123,199 11,587 D
Derivatives
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise · Restricted Stock Units −1,205 1,205 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise · Performance Stock Units −2,050 2,048 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Grant or award · Performance Stock Units +1,030 1,030 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise · Performance Stock Units −515 515 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise · Restricted Stock Units −1,147 2,295 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Grant or award · Performance Stock Units +2,602 2,602 D
Turitz Andrew SVP - BUSINESS DEVELOPMENT 2022-03-02 Option exercise · Performance Stock Units −868 1,734 D
Open-market sales · 1,754 sh · avg $70.24 · $123,199
Loading xslF345X03/form4-03042022_030324.xml…